Peng Liu

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial

Yuankai Shi, Hang Su, Yongping Song et al. · The Lancet Haematology · 2019 · 233 citations

Lymphoid Neoplasia, Medicine, Immunotherapy +2

Liver and spleen volume variations in patients with hepatic fibrosis

Peng Liu, Peng Li, He Wen et al. · World Journal of Gastroenterology · 2009 · 68 citations · Full text

Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study

Jianliang Yang, Lihou Dong, Sheng Yang et al. · European Journal of Cancer · 2020 · 65 citations

Radiation Oncology, Recurrent Malignancies, Malignant Disease +9

Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma

Xiaodong Wang, Jungang Hu, Guang Cao et al. · Radiology · 2016 · 57 citations

National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses

Jian Guo, Peng Liu, Limeng Chen et al. · Orphanet Journal of Rare Diseases · 2021 · 49 citations · Full text